vs
Side-by-side financial comparison of EQUITY BANCSHARES INC (EQBK) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $63.5M, roughly 1.1× EQUITY BANCSHARES INC). EQUITY BANCSHARES INC runs the higher net margin — 34.8% vs -49.0%, a 83.8% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 28.4%). EQUITY BANCSHARES INC produced more free cash flow last quarter ($38.1M vs $-84.7M).
Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
EQBK vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $63.5M | $70.6M |
| Net Profit | $22.1M | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | 41.7% | -56.7% |
| Net Margin | 34.8% | -49.0% |
| Revenue YoY | 28.4% | 81958.1% |
| Net Profit YoY | 30.0% | 54.9% |
| EPS (diluted) | $1.07 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $63.5M | — | ||
| Q3 25 | $18.0M | $70.6M | ||
| Q2 25 | $58.4M | — | ||
| Q1 25 | $60.6M | — | ||
| Q4 24 | $58.3M | — | ||
| Q3 24 | $55.3M | — | ||
| Q2 24 | $55.4M | — | ||
| Q1 24 | $55.9M | — |
| Q4 25 | $22.1M | — | ||
| Q3 25 | $-29.7M | $-34.6M | ||
| Q2 25 | $15.3M | — | ||
| Q1 25 | $15.0M | — | ||
| Q4 24 | $17.0M | — | ||
| Q3 24 | $19.9M | — | ||
| Q2 24 | $11.7M | — | ||
| Q1 24 | $14.1M | — |
| Q4 25 | 41.7% | — | ||
| Q3 25 | -207.2% | -56.7% | ||
| Q2 25 | 31.5% | — | ||
| Q1 25 | 31.1% | — | ||
| Q4 24 | 35.0% | — | ||
| Q3 24 | 43.1% | — | ||
| Q2 24 | 29.4% | — | ||
| Q1 24 | 31.8% | — |
| Q4 25 | 34.8% | — | ||
| Q3 25 | -164.7% | -49.0% | ||
| Q2 25 | 26.1% | — | ||
| Q1 25 | 24.8% | — | ||
| Q4 24 | 29.1% | — | ||
| Q3 24 | 35.9% | — | ||
| Q2 24 | 21.1% | — | ||
| Q1 24 | 25.2% | — |
| Q4 25 | $1.07 | — | ||
| Q3 25 | $-1.55 | — | ||
| Q2 25 | $0.86 | — | ||
| Q1 25 | $0.85 | — | ||
| Q4 24 | $1.06 | — | ||
| Q3 24 | $1.28 | — | ||
| Q2 24 | $0.76 | — | ||
| Q1 24 | $0.90 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $490.9M |
| Total DebtLower is stronger | $443.2M | — |
| Stockholders' EquityBook value | $732.1M | $503.0M |
| Total Assets | $6.4B | $577.1M |
| Debt / EquityLower = less leverage | 0.61× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $490.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $443.2M | — | ||
| Q3 25 | $486.9M | — | ||
| Q2 25 | $448.4M | — | ||
| Q1 25 | $376.9M | — | ||
| Q4 24 | $312.8M | — | ||
| Q3 24 | $437.5M | — | ||
| Q2 24 | $391.7M | — | ||
| Q1 24 | $367.1M | — |
| Q4 25 | $732.1M | — | ||
| Q3 25 | $711.9M | $503.0M | ||
| Q2 25 | $635.6M | — | ||
| Q1 25 | $617.3M | — | ||
| Q4 24 | $592.9M | — | ||
| Q3 24 | $504.0M | — | ||
| Q2 24 | $461.4M | — | ||
| Q1 24 | $456.8M | — |
| Q4 25 | $6.4B | — | ||
| Q3 25 | $6.4B | $577.1M | ||
| Q2 25 | $5.4B | — | ||
| Q1 25 | $5.4B | — | ||
| Q4 24 | $5.3B | — | ||
| Q3 24 | $5.4B | — | ||
| Q2 24 | $5.2B | — | ||
| Q1 24 | $5.2B | — |
| Q4 25 | 0.61× | — | ||
| Q3 25 | 0.68× | — | ||
| Q2 25 | 0.71× | — | ||
| Q1 25 | 0.61× | — | ||
| Q4 24 | 0.53× | — | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 0.85× | — | ||
| Q1 24 | 0.80× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $51.4M | $-84.6M |
| Free Cash FlowOCF − Capex | $38.1M | $-84.7M |
| FCF MarginFCF / Revenue | 60.0% | -120.1% |
| Capex IntensityCapex / Revenue | 20.9% | 0.2% |
| Cash ConversionOCF / Net Profit | 2.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | $88.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $51.4M | — | ||
| Q3 25 | $8.5M | $-84.6M | ||
| Q2 25 | $28.3M | — | ||
| Q1 25 | $21.7M | — | ||
| Q4 24 | $73.8M | — | ||
| Q3 24 | $23.5M | — | ||
| Q2 24 | $16.0M | — | ||
| Q1 24 | $12.6M | — |
| Q4 25 | $38.1M | — | ||
| Q3 25 | $4.5M | $-84.7M | ||
| Q2 25 | $26.0M | — | ||
| Q1 25 | $20.2M | — | ||
| Q4 24 | $65.4M | — | ||
| Q3 24 | $19.7M | — | ||
| Q2 24 | $15.2M | — | ||
| Q1 24 | $10.6M | — |
| Q4 25 | 60.0% | — | ||
| Q3 25 | 24.7% | -120.1% | ||
| Q2 25 | 44.5% | — | ||
| Q1 25 | 33.3% | — | ||
| Q4 24 | 112.1% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 27.4% | — | ||
| Q1 24 | 19.0% | — |
| Q4 25 | 20.9% | — | ||
| Q3 25 | 22.3% | 0.2% | ||
| Q2 25 | 3.9% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 14.6% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 3.6% | — |
| Q4 25 | 2.33× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 1.44× | — | ||
| Q4 24 | 4.35× | — | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 0.90× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
